Asztma: vizsgálatok itt: Izrael
6 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
- Where
- Beersheba, Haifa, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan, Tel Aviv
- Életkor
- 12 év to 80 év
- People
- 786 worldwide
- Run by
- Generate Biomedicines
See details and how to joinNCT07276724 · EU 2025-521950-41-00 - 3. fázisTaking peopleRoll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
- Where
- Haifa, Holon, Petah Tikva
- Életkor
- 6 év and over
- People
- 230 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07444567 - 2. fázisTaking peopleA Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma
- Where
- Tel Aviv
- Életkor
- 18 év to 85 év
- People
- 440 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07746687 · EU 2026-526262-24-00 - 2. fázisTaking peopleDose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Where
- Haifa, Jerusalem, Kfar Saba, Ramat Gan, Rehovot
- Életkor
- 18 év to 75 év
- People
- 540 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06932263 · EU 2024-519116-14-00 - No phaseTaking peoplePost Exacerbation Asthma Clinic Telecare Intervention to Reduce Recurrent Exacerbations
- Where
- Tel Aviv
- Életkor
- 18 év to 75 év
- People
- 220
- Run by
- Tel-Aviv Sourasky Medical Center
See details and how to joinNCT07629830 - 2. fázisCsak meghívásosLong-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
- Where
- Ashkelon, Haifa, Jerusalem, Petah Tikva, Rehovot, Tel Aviv
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00